NCT05838365

Brief Summary

The main aim of the present study is to investigate implant success rate after 5 years of function of immediate (Test group; within 7 days of implant placement) versus delayed (Control group; 8 weeks after implant placement) loading of two-pieces zirconia implant, placed in pristine bone without bone regeneration. Implant success rate will be defined according to Buser's criteria. Secondary endpoints: Marginal bone level (MBL) evaluation by means of standardized radiographs; Clinical evaluation of biological (e.g. Plaque Index, PI; Probing Pocket Depth, PPD, Bleeding on Probing, BOP; suppuration upon probing/palpation) and prosthetic/technical complications; Clinical evaluation of soft tissue width, keratinized tissue, marginal and interproximal soft tissue recession; Patient reported outcome measures (PROMs) by questionnaire administration:

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for phase_4

Timeline
37mo left

Started Dec 2022

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Dec 2022Jun 2029

Study Start

First participant enrolled

December 1, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 5, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 1, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2029

Expected
Last Updated

May 1, 2023

Status Verified

April 1, 2023

Enrollment Period

1.5 years

First QC Date

March 5, 2023

Last Update Submit

April 26, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Implant success rate according to Buser's criteria

    presence of subjective complaints related to the area of treatment; recurrent infections in the peri-implant region accompanied by suppuration; mobility of the implant fixture

    5 years

Study Arms (2)

Immediate loading zirconia implant

EXPERIMENTAL

Loading of zirconia dental implant within 7 days after implant placement

Device: Zirconia implant

Delayed loading zirconia implant

ACTIVE COMPARATOR

Loading of zirconia dental implants after at least 2 months of healing

Device: Zirconia implant

Interventions

(Test group; within 7 days of implant placement) versus delayed (Control group; 8 weeks after implant placement)

Delayed loading zirconia implantImmediate loading zirconia implant

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sistemically healthy patients
  • partial edentulism
  • premolar position
  • molar position
  • Bone width and height at least 6 and 10mm, respectively.
  • Keratinized tissue, at least 1 mm at implant site
  • Full understanding of the proposed surgical treatments and the protocol schedule
  • Full comprehension and availability to sign the informed consent form

You may not qualify if:

  • Heavy smokers (\>10 cigarettes a day)
  • Serious kidney or liver diseases
  • Uncontrolled diabetes
  • Bisphosphonates intake
  • History of radiotherapy of the head and neck
  • Current antiblastic chemotherapy
  • Congenital (primary) or acquired (secondary) immunodeficiency
  • Pregnant women
  • Connective tissue disorders
  • untreated stage III/IV periodontitis
  • Autoimmune diseases
  • oral parafunctions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

San Paolo Hospital

Milan, Italy

RECRUITING

MeSH Terms

Conditions

Peri-Implantitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Principal Investigator

Study Record Dates

First Submitted

March 5, 2023

First Posted

May 1, 2023

Study Start

December 1, 2022

Primary Completion

June 1, 2024

Study Completion (Estimated)

June 1, 2029

Last Updated

May 1, 2023

Record last verified: 2023-04

Locations